KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Payables (2016 - 2025)

Zimmer Biomet Holdings has reported Payables over the past 17 years, most recently at $303.0 million for Q4 2025.

  • Quarterly results put Payables at $303.0 million for Q4 2025, up 55.7% from a year ago — trailing twelve months through Dec 2025 was $303.0 million (up 55.7% YoY), and the annual figure for FY2025 was $303.0 million, up 55.7%.
  • Payables for Q4 2025 was $303.0 million at Zimmer Biomet Holdings, down from $315.3 million in the prior quarter.
  • Over the last five years, Payables for ZBH hit a ceiling of $437.1 million in Q4 2022 and a floor of $194.6 million in Q4 2024.
  • Median Payables over the past 5 years was $328.7 million (2021), compared with a mean of $335.2 million.
  • Biggest five-year swings in Payables: plummeted 52.61% in 2024 and later surged 55.7% in 2025.
  • Zimmer Biomet Holdings' Payables stood at $306.5 million in 2021, then soared by 42.61% to $437.1 million in 2022, then decreased by 6.06% to $410.6 million in 2023, then plummeted by 52.61% to $194.6 million in 2024, then skyrocketed by 55.7% to $303.0 million in 2025.
  • The last three reported values for Payables were $303.0 million (Q4 2025), $315.3 million (Q3 2025), and $348.7 million (Q2 2025) per Business Quant data.